JP5362593B2 - 溶媒を用いずにペプチドを合成する方法 - Google Patents
溶媒を用いずにペプチドを合成する方法 Download PDFInfo
- Publication number
- JP5362593B2 JP5362593B2 JP2009554044A JP2009554044A JP5362593B2 JP 5362593 B2 JP5362593 B2 JP 5362593B2 JP 2009554044 A JP2009554044 A JP 2009554044A JP 2009554044 A JP2009554044 A JP 2009554044A JP 5362593 B2 JP5362593 B2 JP 5362593B2
- Authority
- JP
- Japan
- Prior art keywords
- compound
- group
- formula
- following formula
- iii
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title claims description 28
- 239000002904 solvent Substances 0.000 title claims description 22
- 230000002194 synthesizing effect Effects 0.000 title claims description 6
- 108090000765 processed proteins & peptides Proteins 0.000 title description 8
- 150000001875 compounds Chemical class 0.000 claims description 58
- -1 imidazolylmethyl Chemical group 0.000 claims description 30
- 238000006243 chemical reaction Methods 0.000 claims description 16
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 12
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 12
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 8
- 125000003118 aryl group Chemical group 0.000 claims description 7
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 claims description 6
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 5
- 125000003277 amino group Chemical group 0.000 claims description 5
- 125000001072 heteroaryl group Chemical group 0.000 claims description 5
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 5
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 claims description 5
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims description 4
- 125000000524 functional group Chemical group 0.000 claims description 4
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 4
- 150000004649 carbonic acid derivatives Chemical group 0.000 claims description 3
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- IWDCLRJOBJJRNH-UHFFFAOYSA-N p-cresol Chemical compound CC1=CC=C(O)C=C1 IWDCLRJOBJJRNH-UHFFFAOYSA-N 0.000 claims description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 239000007787 solid Substances 0.000 description 9
- 108010011485 Aspartame Proteins 0.000 description 8
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 8
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 8
- 108010016626 Dipeptides Proteins 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- 239000000605 aspartame Substances 0.000 description 7
- 229960003438 aspartame Drugs 0.000 description 7
- 235000010357 aspartame Nutrition 0.000 description 7
- 238000003786 synthesis reaction Methods 0.000 description 7
- 150000001413 amino acids Chemical class 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 125000006239 protecting group Chemical group 0.000 description 6
- 125000001424 substituent group Chemical group 0.000 description 5
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 0 CC(C)(C)OC(C(C1)C1(C(OCc1ccccc1)=O)N*)=O Chemical compound CC(C)(C)OC(C(C1)C1(C(OCc1ccccc1)=O)N*)=O 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 150000003862 amino acid derivatives Chemical class 0.000 description 2
- 238000000498 ball milling Methods 0.000 description 2
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 2
- 229910000024 caesium carbonate Inorganic materials 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- VSDUZFOSJDMAFZ-VIFPVBQESA-N methyl L-phenylalaninate Chemical compound COC(=O)[C@@H](N)CC1=CC=CC=C1 VSDUZFOSJDMAFZ-VIFPVBQESA-N 0.000 description 2
- 125000004430 oxygen atom Chemical group O* 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 238000007363 ring formation reaction Methods 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 1
- BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical compound C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 description 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
- LJCZNYWLQZZIOS-UHFFFAOYSA-N 2,2,2-trichlorethoxycarbonyl chloride Chemical compound ClC(=O)OCC(Cl)(Cl)Cl LJCZNYWLQZZIOS-UHFFFAOYSA-N 0.000 description 1
- 125000000453 2,2,2-trichloroethyl group Chemical group [H]C([H])(*)C(Cl)(Cl)Cl 0.000 description 1
- HJKLEAOXCZIMPI-UHFFFAOYSA-N 2,2-diethoxyethanamine Chemical class CCOC(CN)OCC HJKLEAOXCZIMPI-UHFFFAOYSA-N 0.000 description 1
- YQTCQNIPQMJNTI-UHFFFAOYSA-N 2,2-dimethylpropan-1-one Chemical group CC(C)(C)[C]=O YQTCQNIPQMJNTI-UHFFFAOYSA-N 0.000 description 1
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 1
- HUHXLHLWASNVDB-UHFFFAOYSA-N 2-(oxan-2-yloxy)oxane Chemical compound O1CCCCC1OC1OCCCC1 HUHXLHLWASNVDB-UHFFFAOYSA-N 0.000 description 1
- 125000003821 2-(trimethylsilyl)ethoxymethyl group Chemical group [H]C([H])([H])[Si](C([H])([H])[H])(C([H])([H])[H])C([H])([H])C(OC([H])([H])[*])([H])[H] 0.000 description 1
- ATVJXMYDOSMEPO-UHFFFAOYSA-N 3-prop-2-enoxyprop-1-ene Chemical compound C=CCOCC=C ATVJXMYDOSMEPO-UHFFFAOYSA-N 0.000 description 1
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- MYPTZCIZNVYJGQ-JTQLQIEISA-N COC([C@H](C#Cc1ccccc1)N)=O Chemical compound COC([C@H](C#Cc1ccccc1)N)=O MYPTZCIZNVYJGQ-JTQLQIEISA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229910000760 Hardened steel Inorganic materials 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical group C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- PUJDIJCNWFYVJX-UHFFFAOYSA-N benzyl carbamate Chemical compound NC(=O)OCC1=CC=CC=C1 PUJDIJCNWFYVJX-UHFFFAOYSA-N 0.000 description 1
- 125000002619 bicyclic group Chemical group 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- ZMCUDHNSHCRDBT-UHFFFAOYSA-M caesium bicarbonate Chemical compound [Cs+].OC([O-])=O ZMCUDHNSHCRDBT-UHFFFAOYSA-M 0.000 description 1
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- PIZLBWGMERQCOC-UHFFFAOYSA-N dibenzyl carbonate Chemical compound C=1C=CC=CC=1COC(=O)OCC1=CC=CC=C1 PIZLBWGMERQCOC-UHFFFAOYSA-N 0.000 description 1
- MHDVGSVTJDSBDK-UHFFFAOYSA-N dibenzyl ether Chemical compound C=1C=CC=CC=1COCC1=CC=CC=C1 MHDVGSVTJDSBDK-UHFFFAOYSA-N 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical compound [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- 150000002081 enamines Chemical class 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 150000002466 imines Chemical class 0.000 description 1
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 125000002950 monocyclic group Chemical group 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000019533 nutritive sweetener Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 125000001712 tetrahydronaphthyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100001274 therapeutic index Toxicity 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
- C07K1/061—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06052—Val-amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06104—Dipeptides with the first amino acid being acidic
- C07K5/06113—Asp- or Asn-amino acid
- C07K5/06121—Asp- or Asn-amino acid the second amino acid being aromatic or cycloaliphatic
- C07K5/0613—Aspartame
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
nは、1以上の整数であり、有利には1〜100を含み、より有利には1〜50を含み、さらにより有利には1または2に等しく;
Rbおよび各Rnは、互いに独立に水素原子、アリール(C1−C6アルキル)基またはC1−C6アルキル基(アリール基、−COOH、−COO−(C1−C6アルキル)、−CONH2、−SH、ヘテロアリール、−NH2、−NHC(NH)(NH2)、−S−(C1−C6アルキル)、−OHまたはフェノール基で置換されている、または置換されていない)を表し、−COOH、NH2、OH、SHおよびNHの基は所望により1以上の同一または異なるN−保護基またはO−保護基で保護され、かつ、Raとは異なり;有利にはこれらのN−保護基またはO−保護基はRa基を除去するための条件下で安定であり;
RaはN−保護基を表し;
Rcは−ORd基を表し、ここで、RdはC1−C6アルキル基または−NReRf基を表し、ここで、ReおよびRfは互いに独立にN−保護基を表す]
の化合物を合成する方法であって、
(a)塩基の存在下で、溶媒を用いずに、下式(II):
の化合物と下式(III):
の化合物ならびにその薬学上許容される塩、好ましくは、塩化物、酢酸塩およびトリフルオロ酢酸塩とを反応させることからなる工程、を含むことを特徴とする方法に関する。
の化合物と反応させて、下式(I−1):
の化合物を得ることからなる。
Ra、ReおよびRfは、互いに独立に、tert−ブチルオキシカルボニル、9−フルオレニルメチルオキシカルボニル、ベンジルオキシカルボニル、ニトロ−ベラトリルオキシカルボニルからなる群から選択され、かつ/または
Rbは、イソプロピル、ベンジルおよび−CH2COOt−Buからなる群から選択され、かつ/または
各Rnは、互いに独立に、メチル、ベンジルおよび−CH2CH(CH3)2からなる群から選択され、かつ/または
Rdは、メチルおよびテルチオブチルからなる群から選択される。
化合物(III)は、下式(III−a)、(III−b)、(III−c)、(III−d)および(III−e):
式(II)の化合物は下式(II−2):
を有し、
式(III)の化合物は下式(III−2):
式(I)の化合物は下式(I−2):
を有する。
1)下式(IV):
2)式(V)の化合物を、塩基、有利には炭酸セシウムの存在下でハロゲン化ベンジルと反応させて、下式(VI):
の化合物を得ること;
3)式(VI)の化合物のアミン基をN−保護基Rgで保護して、下式(VII):
の化合物を形成させること;
4)式(VII)の化合物を下式(VIII):
の化合物へと還元すること;
5)式(VIII)の化合物を、DMFおよび塩化オキサリルとの反応により式(II−2)の化合物へと環化すること
を含んでなる方法により製造することができる。
(b)工程(a)で得られた式(I−2)の化合物を酸、有利には塩酸ガス、と反応させて、下式(I−3):
(c)式(I−3)の化合物を塩基、有利には炭酸水素ナトリウム、と反応させて、下式(I−4):
を含んでなる。
アスパルテーム、またはα−L−アスパルチル−L−フェニルアラニン−メチルエステルは、サッカロースよりもおよそ150倍甘い栄養甘味料である。これは商業上魅力的なジペプチドであるが、溶媒の存在下でも不在下でもUNCAからは未だ製造されていない。
この方法は、アミン官能基を保護するBocを1つ含む主鎖を有する遊離カルボン酸の環化からなり、従って、まず、(Boc)2−Asp(O−t−Bu)−OH(VII−a)の製造を必要とする。これは、Boc−Asp(O−t−Bu)−OH(V−a)のα−カルボン酸をベンジルエステル(VI(a))へとエステル化した後、DMAPの存在下でBoc2Oと反応させて、2つのBoc基で保護されたアミノ化合物(VII−a)を得、その後、水素化によりこのベンジルエステル基を脱保護して(VIII−a)を得ることにより達成した。
Claims (11)
- 下式(I):
nは、1以上の整数であり;
Rbおよび各Rnは、互いに独立に水素原子、アリール(C1−C6アルキル)基またはC1−C6アルキル基(アリール基、−COOH、−COO−(C1−C6アルキル)、−CONH2、−SH、ヘテロアリール、−NH2、−NHC(NH)(NH2)、−S−(C1−C6アルキル)、−OHまたはフェノールで置換されている、または置換されてない)を表し、ここでNH2、NH、COOH、OH、SHの官能基は、1以上の同一または異なるN−保護基またはO−保護基で保護されていてもよく、かつ、Raとは異なり;
Raは、N−保護基を表し;
Rcは、−ORd基を表し、ここで、RdはC1−C6アルキル基または−NReRf基を表し、ここで、ReおよびRfは互いに独立にN−保護基を表す]
の化合物を合成する方法であって、下記工程:
(a)塩基の存在下で、いずれの溶媒も用いずに、下式(II):
の化合物と、下式(III):
の化合物ならびにその薬学上許容される塩とを反応させること
を含んでなる、方法。 - 工程(a)が、ボールミルの手段により行われる、請求項1または2に記載の方法。
- 塩基が、炭酸塩からなる群から選択される、請求項1〜3のいずれか一項に記載の方法。
- Rbおよび各Rnが、水素、−CH3、ベンジル基、−CH2CONH2、−CHCH3C2H5、−(CH2)3NHC(NH)(NH2)、−CH(OH)CH3、−CH2COOH、−CH2SH、−CH2CH2COOH、−CH2CH2CONH2、イミダゾリルメチル、プロピル、−CH2CH(CH3)2、−(CH2)4NH2、−(CH2)2SCH3、−CH2OH、インドール−2−イルメチル、p−メチルフェノール、イソプロピル基からなる群から独立に選択され、これらの基のNH2、NH、COOH、SHおよびOH官能基が、1以上の同一または異なるO−保護基および/またはN−保護基で保護されていてもよく、かつ、Raとは異なる、請求項1〜4のいずれか一項に記載の方法。
- Ra、ReおよびRfが、互いに独立に、tert−ブチルオキシカルボニル、9−フルオレニルメチルオキシカルボニル、ベンジルオキシカルボニル、ニトロ−ベラトリルオキシカルボニルからなる群から選択され;
Rbが、イソプロピル、ベンジルおよび−CH2COOt−Buからなる群から選択され;
各Rnが、互いに独立に、メチル、ベンジルおよび−CH2CH(CH3)2からなる群から選択され;
Rdが、メチルおよびテルチオブチルからなる群から選択される、請求項1〜4のいずれか一項に記載の方法。 - 式(II−2)の化合物が、下記の一連の工程:
1)下式(IV):
2)式(V)の化合物を、塩基の存在下でハロゲン化ベンジルと反応させて、下式(VI):
の化合物を得ること;
3)式(VI)の化合物のアミン基をN−保護基Rgで保護して、下式(VII):
の化合物を形成させること;
4)式(VII)の化合物を、下式(VIII):
の化合物へと還元すること;
5)式(VIII)の化合物を、DMFおよび塩化オキサリルとの反応により、式(II−2)の化合物へと環化すること
を含んでなる方法により製造される、請求項8に記載の方法。 - RaおよびRgが、tert−ブチルオキシカルボニルである、請求項9に記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0753970A FR2913978B1 (fr) | 2007-03-21 | 2007-03-21 | Procede de synthese de peptides sans solvant |
FR0753970 | 2007-03-21 | ||
PCT/EP2008/053444 WO2008125418A2 (fr) | 2007-03-21 | 2008-03-21 | Procede de synthese de peptides sans solvant |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2010522144A JP2010522144A (ja) | 2010-07-01 |
JP5362593B2 true JP5362593B2 (ja) | 2013-12-11 |
Family
ID=38293308
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009554044A Expired - Fee Related JP5362593B2 (ja) | 2007-03-21 | 2008-03-21 | 溶媒を用いずにペプチドを合成する方法 |
Country Status (8)
Country | Link |
---|---|
US (1) | US7960578B2 (ja) |
EP (1) | EP2139910B1 (ja) |
JP (1) | JP5362593B2 (ja) |
AT (1) | ATE510843T1 (ja) |
CA (1) | CA2681321A1 (ja) |
ES (1) | ES2366001T3 (ja) |
FR (1) | FR2913978B1 (ja) |
WO (1) | WO2008125418A2 (ja) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2691223T3 (es) * | 2014-05-28 | 2018-11-26 | Astrazeneca Ab | Proceso para la preparación de AZD5363 e intermedio novedoso utilizado en el mismo |
EP3527580B1 (en) * | 2018-02-16 | 2021-04-07 | Centre National de la Recherche Scientifique CNRS | Continuous, solvent-free and non-enzymatic peptide synthesis by reactive extrusion |
JP7356707B2 (ja) * | 2018-11-15 | 2023-10-05 | 国立大学法人神戸大学 | アミノ酸-n-カルボン酸無水物の製造方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU673731B2 (en) * | 1993-06-03 | 1996-11-21 | Banyu Pharmaceutical Co., Ltd. | Novel endothelin antagonistic peptide |
FR2858976B1 (fr) * | 2003-08-22 | 2006-02-10 | Isochem Sa | Procede d'obtention de n-carboxyanhydrides d'alpha-aminoacides a protection urethane |
-
2007
- 2007-03-21 FR FR0753970A patent/FR2913978B1/fr not_active Expired - Fee Related
-
2008
- 2008-03-21 US US12/531,972 patent/US7960578B2/en not_active Expired - Fee Related
- 2008-03-21 ES ES08718144T patent/ES2366001T3/es active Active
- 2008-03-21 JP JP2009554044A patent/JP5362593B2/ja not_active Expired - Fee Related
- 2008-03-21 CA CA002681321A patent/CA2681321A1/fr not_active Abandoned
- 2008-03-21 WO PCT/EP2008/053444 patent/WO2008125418A2/fr active Application Filing
- 2008-03-21 AT AT08718144T patent/ATE510843T1/de not_active IP Right Cessation
- 2008-03-21 EP EP08718144A patent/EP2139910B1/fr not_active Not-in-force
Also Published As
Publication number | Publication date |
---|---|
WO2008125418A2 (fr) | 2008-10-23 |
FR2913978B1 (fr) | 2009-07-03 |
ES2366001T3 (es) | 2011-10-14 |
ATE510843T1 (de) | 2011-06-15 |
CA2681321A1 (fr) | 2008-10-23 |
FR2913978A1 (fr) | 2008-09-26 |
EP2139910B1 (fr) | 2011-05-25 |
US20100016631A1 (en) | 2010-01-21 |
EP2139910A2 (fr) | 2010-01-06 |
WO2008125418A3 (fr) | 2008-12-18 |
JP2010522144A (ja) | 2010-07-01 |
US7960578B2 (en) | 2011-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0595345B1 (en) | Process for producing alanylglutamine | |
AU2003300689B2 (en) | Novel method for preparation of crystalline perindopril erbumine | |
EP1870411B1 (en) | Process for the preparation and purification of valgancyclovir | |
KR20010101750A (ko) | 치환 페네틸아민 유도체 | |
JP5362593B2 (ja) | 溶媒を用いずにペプチドを合成する方法 | |
CA2461087A1 (en) | Process for the preparation of repaglinide | |
JPH06234715A (ja) | アラニルグルタミンの製造法 | |
TWI383995B (zh) | 擬脯胺酸二肽 | |
AU2003224420B2 (en) | Process for preparation of perindopril and salts thereof | |
EP2272830A1 (en) | Preparation process of an antivirally heterocyclic azahexane derivative | |
CA2166246A1 (en) | Process of producing .alpha.-l-aspartyldipeptide amide derivatives | |
EP2314562A2 (en) | Improved preparation of 2S,3S-N-isobutyl-N-(2-hydroxy-3-amino-4-phenylbutyl)-p-nitrobenzenesulfonylamide hydrochloride and other derivatives of 2-hydroxy-1,3-diamines | |
JP5152180B2 (ja) | バラシクロビルの製造方法 | |
US9416105B2 (en) | Process for preparation of saxagliptin and its hydrochloride salt | |
JP2004504405A (ja) | 化学的方法 | |
US8664443B2 (en) | Process for the preparation of (1S, 3S, 5S)-2-[2(S)-2-amino-2-(3-hydroxy-1-adamantan-1-yl) acetyl]-2-azabicyclo [3.1.0] hexane-3-carbonitrile | |
JP2000351740A (ja) | アミノイソ酪酸の光学分割 | |
WO1997041093A1 (en) | Methods for the synthesis of fmoc protected amines | |
JP2000026383A (ja) | テアニンの製造方法 | |
JP2880744B2 (ja) | α―L―アスパルチル―L―フェニルアラニンエステルの製造法 | |
JP5982720B2 (ja) | 高分子固体状支持体を用いたヒスチジル−プロリンアミド誘導体の製造方法 | |
CA2243972C (en) | Process for preparing purine derivatives | |
JP2005154430A (ja) | ピリミジン誘導体の製造方法、および中間体とその製造方法 | |
JPH06116216A (ja) | N−保護−アミノアルデヒドの製造方法 | |
JPS58222052A (ja) | アミド結合形成用縮合剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20110302 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130118 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20130411 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20130418 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20130513 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20130520 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20130617 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20130624 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130718 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20130809 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20130904 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
LAPS | Cancellation because of no payment of annual fees |